by Samantha J. Snow, PhD, PDA Vice-Chair
The Postdoctoral Assembly (PDA) Executive Board is pleased to announce the recipients of the 2017 Best Postdoctoral Publication Award (BPPA)! The BPPA recognizes talented postdoctoral researchers who have recently published papers in the field of toxicology as a result of their work conducted during their postdoctoral research experience. The awards will be presented at the PDA Luncheon during the SOT 2017 Annual Meeting in March. Each award recipient will receive $250 and a plaque recognizing their achievement.
A Chemical–Biological Similarity-Based Grouping of Complex Substances as a Prototype Approach for Evaluating Chemical Alternatives, Green Chemistry, 2016 May, 18: 4407-19
Fabian Grimm, PhD, Texas A&M University
His advisor Ivan Rusyn says of this paper, "The problem that this paper addresses is not theoretical, it is very palpable and with real implications for breaking a regulatory impasse in Europe over REACH registration of petroleum substances.”
Global Marine Pollutants Inhibit P-glycoprotein: Environmental Levels, Inhibitory Effects, and Cocrystal Structure, Science Advances, 2016 Apr, 2(4): e1600001
Sascha C.T. Nicklisch, PhD, University of California, San Diego
His advisor Amro Hamdoun stated “Until this study, there was very little known about how [drug transporters] interact with environmental chemicals. This is a landmark study that takes a major step towards defining a molecular mechanism for persistence. This is also the first study showing how an environmentally relevant mixture of these chemicals found in food fish can interfere with P-glycoprotein (P-gp), arguably the most important of the mammalian drug transporters.”
Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423, Toxicological Science, 2016 Jul, 152(1): 205-213
Mira Pavkovic, PhD, Harvard Medical School
Her advisor Vishal Vaidya says “There is an urgent need for new biomarkers to not only help in timely and specific diagnosis of Acute Kidney Injury (AKI) in patients but also to enable improved stratification of patients with AKI in clinical trials to facilitate development of therapies for kidney injury. Here, we provide a novel approach by combining the sensitivity/specificity of Kidney Injury Molecule-1 (KIM-1) along with mechanistic potentials of three urinary miRNAs for non-invasive detection of AKI in humans.”
Congratulations to each of the awardees. These papers and the others submitted demonstrate the important research that is conducted during postdoctoral studies.